Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 18 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Information processing apparatus, method for controlling information processing apparatus, and storage medium
Active constant power supply apparatus
Method for generating multi-antenna signals
Cardiac function management integrating cardiac contractility modulation
Wide viewing angle indicators for network devices
Chip on chip semiconductor device including an underfill layer having a resin containing an amine-based curing agent
  Randomly Featured Patents
Shoe upper
Photoelectric switch
Methods and apparatus for isotopic analysis
Support assembly for supporting a fixture on a wall
Time striking device for timepiece
CMOS circuit technique for improved switching speed of single-ended and differential dynamic logic
Threading of mixed media
Plasma reactor with a deposition shield
Communication system, network handover processing method and apparatus
Optical film and process for manufacture thereof